Liposomal Bupivacaine Shows Limited Clinical Benefit After Third Molar Extraction

Extended-release anesthetic did not significantly improve postoperative pain, raising questions about its routine use in dental surgery.

By
Olivia Anderson
March 25, 2026
3 min

Conexiant

Original Source(s)

Conexiant

Liposomal Bupivacaine Shows Limited Clinical Benefit After Third Molar Extraction

by Olivia Anderson
March 25, 2026

Related Content

The Medicine Maker

Turning Baby Teeth Into Cell Therapy

SHED cells show early promise as a potential regenerative therapy in cerebral palsy research

March 26, 2026
3 min

Jama Network Open

Opioid Use and Pain Resolution for Acute Pain Among Opioid-Naive Patients

by Molly Moore Jeffery, Fernanda Bellolio, Nancy Chang, Summer Allen, Marie-Carmelle Elie-Turenne, W. Jonathan Fillmore, Gregg H. Gilbert, Rebekah Heckmann, Patricia Koussis, Christine Lee, Heather Lipkind, Tamra E. Meyer, Teryl K. Nuckols, Jessica D. Ritchie, Michael A. Pacanowski, David B. Page, Mat Soukup, Stephen Tamang, Sam Torbati, Doug Wallace, Lauren Walter, Yueqin Zhao, Nilay D. Shah, Mitra Ahadpour, Joseph S. Ross
July 7, 2026

Conexiant

Pain With Movement Linked to Poorer Outcomes in TMD

Systematic review identifies key prognostic factors for TMD pain and function but emphasizes low-certainty evidence and need for more rigorous research.

by Olivia Anderson
March 25, 2026
3 min